Sale!

HLA Pre-Transplant Workup Sensitized Recipient Panel 5 Test

7,800 د.إ

-25%

The “HLA Pre-Transplant Workup Sensitized Recipient Panel 5 Test” is a specialized diagnostic procedure offered by DNA Labs UAE, designed to assess the compatibility between organ transplant donors and recipients, with a focus on individuals who are highly sensitized. This test is crucial for identifying potential human leukocyte antigen (HLA) mismatches that could lead to transplant rejection, a common concern for sensitized recipients who have developed antibodies against foreign HLA due to previous transplants, blood transfusions, or pregnancies.

The panel involves a comprehensive screening for antibodies against HLA, providing a detailed profile that helps in the selection of a compatible donor, thereby increasing the success rate of the transplant. This advanced immunological assessment plays a pivotal role in the pre-transplant evaluation process, guiding clinicians in their decision-making to minimize the risk of acute or chronic rejection episodes.

Priced at 7800 AED, the test is conducted in the state-of-the-art facilities of DNA Labs UAE, which is equipped with the latest technologies and staffed by experienced professionals. This investment is vital for sensitized patients awaiting transplants, as it significantly enhances the likelihood of a successful outcome by facilitating the identification of a suitable donor match, ultimately improving patient survival and quality of life post-transplant.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

HLA PRE-TRANSPLANT WORKUP SENSITIZED RECIPIENT PANEL 5 Test

Test Name: HLA PRE-TRANSPLANT WORKUP SENSITIZED RECIPIENT PANEL 5 Test

Components:

  • Recipient: HLA DNA Typing for Kidney / Liver transplant, PCR Low resolution Luminex
  • HLA T & B cell lymphocyte flow cytometry cross match vs potential donor
  • Single antigen bead (SAB) IgG Class I & II Luminex

Price: 7800.0 AED

Sample Condition:

  • RECIPIENT: 9 mL (6 mL min.) serum from 3 SST’s AND 4 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube AND 4 mL (2 mL min.) whole blood in 1 Green Top (Sodium Heparin) tube.
  • Collect specimen preferably 48 hours after dialysis.
  • Ship at 18-22°C. DO NOT REFRIGERATE OR FREEZE.
  • Doctor’s prescription on the letterhead with 1 photograph each of recipient and donor duly stamped AND Consent form for HLA Typing for Solid organ transplant (Form 33) is mandatory.

Report Delivery: 10-12 days

Method: Reverse SSOP – Luminex, Luminex X-Map technology, Flow cytometry

Test Type: Transplantation

Doctor: Nephrologist

Test Department:

Pre Test Information: Collect specimen preferably 48 hours after dialysis. Doctor’s prescription on the letterhead with 1 photograph each of recipient and donor duly stamped AND Consent form for HLA Typing for Solid organ transplant (Form 33) is mandatory.

Test Details:

The Sensitized Recipient Panel 5 (SRP5) test is a laboratory test that is used to determine the level of sensitization of a potential organ transplant recipient. The test is typically performed prior to a transplant to assess the risk of rejection and to determine the compatibility of the donor organ.

The SRP5 test specifically measures the level of antibodies in the recipient’s blood against five common human leukocyte antigen (HLA) types. HLA are proteins found on the surface of cells that play a critical role in the immune system’s recognition of self and non-self cells. The higher the level of antibodies against a particular HLA type, the more likely the recipient is to reject an organ from a donor with that HLA type.

The SRP5 test is typically performed using a blood sample from the recipient. The sample is then analyzed in a laboratory to measure the level of antibodies against each of the five HLA types. The results of the test are used to determine the likelihood of a successful transplant and to guide the selection of a compatible donor organ.

In general, a lower level of antibodies against the five HLA types tested in the SRP5 test is associated with a lower risk of rejection and a higher likelihood of a successful transplant. However, each case is unique, and other factors, such as the overall health of the recipient and the quality of the donor organ, must also be considered in determining the best course of treatment.

Test Name HLA PRE-TRANSPLANT WORKUP SENSITIZED RECIPIENT PANEL 5 Test
Components Recipient : *HLA DNA Typing for Kidney / Liver transplant, PCR Low resolution Luminex*HLA T & B cell lymphocyte flow cytometry cross match vs potential donor*Single antigen bead (SAB) IgG Class I & II Luminex
Price 7800.0 AED
Sample Condition RECIPIENT: 9 mL (6 mL min.) serum from 3 SST’s AND 4 mL ( 2 mL min.) whole blood in 1 Lavender top (EDTA) tube AND4 mL (2 mL min.) whole blood in 1 Green Top (Sodium Heparin) tube. Collect specimen preferably 48 hours after dialysis. Ship at 18\u0192??22?\u00f8C. DO NOT REFRIGERATE OR FREEZE. Doctor’s prescription on the letter head with 1 photograph each of recipient and donor duly stamped AND Consent form for HLA Typing for Solid organ transplant (Form 33) is mandatory.
Report Delivery 10-12 days
Method Reverse SSOP – Luminex, Luminex X-Map technology, Flow cytometry
Test type Transplantation
Doctor Nephrologist
Test Department:
Pre Test Information Collect specimen preferably 48 hours after dialysis. Doctor’s prescription on the letter head with 1 photograph each of recipient and donor duly stamped AND Consent form for HLA Typing for Solid organ transplant (Form 33) is mandatory.
Test Details

The Sensitized Recipient Panel 5 (SRP5) test is a laboratory test that is used to determine the level of sensitization of a potential organ transplant recipient. The test is typically performed prior to a transplant to assess the risk of rejection and to determine the compatibility of the donor organ.

The SRP5 test specifically measures the level of antibodies in the recipient’s blood against five common human leukocyte antigen (HLA) types. HLA are proteins found on the surface of cells that play a critical role in the immune system’s recognition of self and non-self cells. The higher the level of antibodies against a particular HLA type, the more likely the recipient is to reject an organ from a donor with that HLA type.

The SRP5 test is typically performed using a blood sample from the recipient. The sample is then analyzed in a laboratory to measure the level of antibodies against each of the five HLA types. The results of the test are used to determine the likelihood of a successful transplant and to guide the selection of a compatible donor organ.

In general, a lower level of antibodies against the five HLA types tested in the SRP5 test is associated with a lower risk of rejection and a higher likelihood of a successful transplant. However, each case is unique, and other factors, such as the overall health of the recipient and the quality of the donor organ, must also be considered in determining the best course of treatment.